Animal Health Biopharma Therapeutics sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Animal Health Biopharma Therapeutics
1.1 - About Animal Health Biopharma Therapeutics sector
Companies in the Animal Health Biopharma Therapeutics category research, develop, and manufacture biologic and small‑molecule treatments for companion and production animals. They deliver preventive and therapeutic solutions—such as vaccines, parasiticides, anti‑infectives, and novel biologics—designed to control disease, improve welfare, and enhance productivity. These vendors combine R&D expertise with GMP manufacturing and regulatory know‑how to bring veterinary medicines to market efficiently and at scale.
Typical offerings span vaccine discovery and scale‑up, monoclonal antibody and protein therapeutics, small‑molecule anti‑infectives and parasiticides, and sterile formulation with fill‑finish. Companies provide GLP preclinical testing, field efficacy trials, and GMP biologics manufacturing, supported by analytical method development, stability programs, and cold‑chain logistics. Many also deliver regulatory strategy for USDA Center for Veterinary Biologics and FDA CVM dossiers, pharmacovigilance post‑market, and contract development and manufacturing services tailored to animal health pipelines.
Primary customer segments include animal health manufacturers, veterinary hospital networks, and livestock producers. These companies help accelerate product approvals, extend therapeutic portfolios, and ensure reliable supply, driving reduced disease incidence, higher herd productivity, and improved clinical outcomes for companion animals. They also enable cost‑efficient scale‑up and compliance, supporting market expansion into new geographies and species for strategic buyers and operators in animal health.
2. Buyers in the Animal Health Biopharma Therapeutics sector
2.1 Top strategic acquirers of Animal Health Biopharma Therapeutics companies
Zoetis
- Description: Provider of animal health solutions specializing in the discovery, development, manufacture and commercialization of parasiticides, vaccines, dermatology treatments, anti-infectives, pain and sedation medicines and diagnostic technologies for veterinarians, livestock producers and pet owners worldwide.
- Key Products:
- Vaccines: Broad portfolio such as Vanguard produced through in-house R&D and global plants to immunize pets and livestock against multiple infectious diseases, helping veterinarians prevent outbreaks and improve herd health
- Parasiticides: Oral and topical treatments, including Simparica Trio, formulated to kill fleas, ticks and internal parasites, providing long-lasting protection and reducing zoonotic risks for companion animals
- Diagnostic Services: VetScan Imagyst platform and reference laboratories deliver AI-powered cytology and rapid testing that give clinicians accurate, same-day diagnostic insights to guide treatment decisions
- Contract Manufacturing Services: End-to-end production of animal health biologics and pharmaceuticals for third-party customers, leveraging Zoetis’ multi-country manufacturing network to ensure quality, regulatory compliance and scaled supply.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Animal Health Biopharma Therapeutics sector
M&A buyer group 1: Veterinary Health Products
IDEXX
- Type: N/A
- Employees: ●●●●●
- Description: Provider of veterinary, water, livestock and human health diagnostics, laboratory services, and practice management software, delivering pet-side tests, bench-top analyzers, 24/7 reference labs, microbiology water tests, and informatics solutions to customers in more than 175 countries.
- Key Products:
- ezyVet: Cloud-based practice management platform with configurable features and robust integrations that streamline daily workflows across scheduling, records and billing while scaling with growing veterinary practices
- Neo: Simple cloud PIMS featuring an intuitive interface that is quick to implement and can complete common workflows up to 5x faster, easing daily tasks for clinic staff
- Cornerstone: Comprehensive server-based practice management software offering customizable features and diverse integrations to manage records, invoicing and diagnostics and support exceptional patient care
- VetConnect PLUS: Diagnostic platform that integrates with IDEXX PIMS to consolidate current and historical in-house and reference lab results, delivering clinical insights from a single, seamless workspace.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Animal Health Biopharma Therapeutics sector
3.1 - Buyout funds in the Animal Health Biopharma Therapeutics sector
2.2 - Strategic buyer groups for Animal Health Biopharma Therapeutics sector
4 - Top valuation comps for Animal Health Biopharma Therapeutics companies
4.2 - Public trading comparable groups for Animal Health Biopharma Therapeutics sector
Valuation benchmark group 1: Prophylactic Vaccine Manufacturing Companies
Merck
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative healthcare, life science, and electronics products and services, leveraging a broad technology portfolio to support the pharmaceutical, biotech, industrial, and diagnostics sectors, aiming to improve health and quality of life through scientific advancements and sustainable solutions.
- Key Products:
- Healthcare: Development and production of medicines and intelligent devices for ongoing patient care
- Life Science: Reagents, consumables, devices, and services for scientific discovery and biomanufacturing
- Electronics: Materials and solutions for the semiconductor and display industries
- Analytical Products: Test assays, analytical reagents, and flow cytometry kits
- BioReliance: Biosafety testing and analytical development services for global clients.